EMBLAVEO

AZTREONAM AND AVIBACTAM · AbbVie Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EMBLAVEO, covering 2025-02-07 to 2026-02-23. Get the full timeline:

Most recent: EMA Authorised: Emblaveo (avibactam;aztreonam) — Pfizer Europe MA EEIG